Oxidative burst of neutrophils in patients with rheumatoid arthritis: Influence of various cytokines and medication

Clinical and Experimental Rheumatology

Volumn 15, Issue 3, 1997, Pages 233-237

  Mur, E ^a   Zabernigg, A ^a   Hilbe, W ^a   Eisterer, W ^a   Halder, W ^a   Thaler, J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

antirheumatic medication; cytokines; granulocytes; Oxidative burst; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; CYTOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; RHEUMATOID ARTHRITIS; TISSUE INJURY;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; REFERENCE VALUES; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030988589     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. GREENWALD RA: Oxygen radicals, inflammation and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum 1991; 20: 219-40.
2. AREND WP, DAYER J-M: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305-15.
3. DUFF GW: Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheumatol Suppl 1994; 100: 9-19.
4. KOWANKO IC, FERRANTE A: Granulocyte-macrophage colony-stimulating factor augments neutrophil-mediated cartilage degradation and neutrophil adherence. Arthritis Rheum 1991; 34: 1452-60.
5. TWOMEY BM, DALE MM: Cyclooxygenase-independent effects of non-steroidal anti-inflammatory drugs on the neutrophil respiratory burst. Biochem Pharmacol 1992; 43: 413-8.
6. KAPLAN HB, EDELSON HS, KORCHAK HM, GIVEN WP, ABRAMSON S, WEISSMAN G: Effects of non-steroidal antiinflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol 1984; 33: 371-8.
7. AL BALLA S, JOHNSTON C, DAVIS P: The in vivo effect of nonsteroid antiinflammatory drugs, gold sodium thiomalate and methotrexate on neutrophil Superoxide radical generation. Clin Exp Rheumatol 1990; 8; 41-5.
8. COATES TD, BARUCH W, TZENG DY, HIGGINS C, BAEHNER RL, BOXER LA: The mechanisms of action of the antiinflammatory agents dexamethasone and auranofin in human polymorphonuclear leukocytes. Blood 1983; 62: 1070-7.
9. NEAL TM, VISSERS MCM, WINTERBOURN CC: Inhibition by nonsteroidal anti-inflammatory drugs of Superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formylmethionyl-leucyl-phenylalanine. Biochem Pharm 1987; 36:15: 2511-7.
10. PRONAI L, ICHIGAWA Y, ICHIMORI K, NAKAZAWA H, ARIMORI S: Association of enhanced Superoxide generation by neutrophils with low Superoxide scavanging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting antirheumatic drugs and disease activity. Clin Exp Rheumatol 1991; 9: 149-55.
11. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
12. STEINBROCKER O, TRAEGER CH, BATTERMAN RG: Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
13. ZABERNIGG A, HILBE W, EISTERER W, GREIL R, LUDESCHER C, THALER J: Defects in cytokine priming of granulocyte respiratory burst in myelodysplastic syndromes. Leukemia Lymphoma, 1996 (in press).
14. YUO A, KITAGAWA S, OHSAKA A, SAITO M, TAKAKU F: Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: qualitative and quantitative differences. Biochem Biophys Res Comm 1990; 31: 491-7.
15. NURCOMBE HL, BUCKNALL RC, EDWARDS SW, Neutrophils from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivo. Ann Rheum Dis 1991; 50: 147-53.
16. ENGLISH D, BROXMEYER HE, GABIG TG, AKARD LP, WILLIAMS DE, HUFFMAN R: Temporal adaption of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanin (acceleration by granulocyte-macrophage colony stimulating factor). J Immunol 1988; 141: 2400-6.
17. ATKINSON YH, MARASCO WA, LOPEZ AF, VADAS MA: Recombinant human tumor necrosis factor α. Regulation of n-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest 1988; 81: 759-65.
18. LOPEZ AF, WILLIAMSON DJ, GAMBLE JR, BEGLEY CG, HARLAN JM, KLEBANOFF SJ, WALTERSDORPH A, WONG G, CLARK SC, VADAS MA: Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest 1986; 78: 1220-8.
19. STENSON WF, MEHTA J, SPILBERG I: Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (fMLP) to its receptor on human neutrophils. Biochem Pharm 1984; 33: 407-12.
20. LAURINDO IMM, MELLO SBV, COSSERMELLI W: Influence of low doses of methotrexate on Superoxide anion production by polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Rheumatol 1995; 22: 633-8.